Therefore, targeting key nodes within the macrophage metabolic-signaling network—such as PPARγ/CD36, Foxo1 phosphorylation, mitophagy, and glycolytic enzymes—may offer multi-mechanism therapeutic strategies for liver fibrosis. This evidence concerns the gene FOXO1 and Hepatic fibrosis.